Furthermore, it has been shown to modulate key pathways—namely, cell cycle arrest, apoptosis, angiogenesis and senescence—through HDAC inhibition both in in vitro and in vivo PCa models [46,47]. The gene discussed is HDAC9; the disease is posterior cortical atrophy.